Detalhe da pesquisa
1.
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients.
J Antimicrob Chemother
; 78(7): 1644-1648, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248664